Literature DB >> 23433917

Vaccinations for international travellers travelling from Greece.

Androula Pavli1, Athina Spilioti, Ioanna Lymperi, Panagiotis Katerelos, Helena C Maltezou.   

Abstract

The aim of this prospective, questionnaire-based study is to assess pre-travel vaccinations for international travellers who receive pre-travel advice in Greece. A total of 2494 travellers were studied from January 1, 2009 through December 31, 2010. Travellers sought pre-travel advice at a median of 16 days (range: 0-349 days) before departure. Sub-Saharan Africa was the most common destination (34.7%). Most travellers (60.8%) travelled for <1 month, for recreation purposes (58.9%), stayed in hotels (65.3%), and in urban areas (53.6%). Yellow fever, tetravalent meningococcal, typhoid fever, cholera, and rabies vaccines were administered to 1629 (65.3%), 666 (26.7%), 615 (24.7%), 28 (1.1%), and/or 12 (0.5%) travellers, respectively. Of those who received Yellow fever vaccine, 737 (45.2%) travelled to sub-Saharan Africa, 332 (20.4%) travelled to South America, 949 (58.3%) stayed for short term, and 762 (46.8%) stayed in urban areas. Of the 1629 travellers vaccinated against Yellow fever, 150 (9.2%) and 226 (13.8%) travelled to areas of sub-Saharan Africa and South America respectively, where the vaccine is not or generally not recommended. Of those travellers who received meningococcal vaccine, 327 (49.1%) travelled to the Middle East for the Hajj, 251 (29%) travelled to sub-Saharan Africa, 410 (61.6%) for short term, and 540 (64.4%) stayed in urban areas. Of those travellers who received typhoid vaccine, 241 (39.2%) travelled to sub-Saharan Africa, 78 (12.7%) to the Indian subcontinent, 234 (38%) for short term, and 419 (68.1%) stayed in urban areas. Regarding routine vaccines, tetanus-diphtheria, poliomyelitis, and measles-mumps-rubella vaccines were administered to 707 (28.3%), 639 (25.6%) and/or 149 (6%) travellers, respectively. Of those to whom poliomyelitis vaccine was recommended, 295 (46.2%) and 137 (21.4%) travelled to sub-Saharan Africa and the Middle East, respectively, and 362 (56.7%) travelled for short term. In conclusion, this study revealed that there is a need for more selective vaccine recommendations for travellers to developing countries, taking under consideration travellers and travel characteristics as well. Strategies to target travel health consultants should be developed in order to increase awareness in travel health issues.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Pre-travel; Rabies; Typhoid; Vaccination; Yellow fever

Mesh:

Substances:

Year:  2013        PMID: 23433917     DOI: 10.1016/j.tmaid.2012.11.007

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  5 in total

1.  Vaccination and Malaria Prevention among International Travelers Departing from Athens International Airport to African Destinations.

Authors:  Androula Pavli; Athina Spilioti; Paraskevi Smeti; Stavros Patrinos; Helena C Maltezou
Journal:  J Trop Med       Date:  2014-03-02

Review 2.  Vaccination in Hajj: An Overview of the Recent Findings.

Authors:  Seyed Mansour Razavi; Mina Saeednejad; Payman Salamati
Journal:  Int J Prev Med       Date:  2016-12-15

3.  Vaccination and malaria prophylaxis among Greek international travelers to Asian destinations.

Authors:  Androula Pavli; Chrysovalantis Silvestros; Stavros Patrinos; Helena C Maltezou
Journal:  J Infect Public Health       Date:  2014-08-14       Impact factor: 3.718

4.  Profile and complexity of travel medicine consultations in Chile: unicentric cross-sectional study.

Authors:  Thomas Weitzel
Journal:  BMJ Open       Date:  2020-09-03       Impact factor: 2.692

5.  Characteristics and potential quality indicators for evaluating pre-travel consultations in Japan hospitals: the Japan Pretravel consultation registry (J-PRECOR).

Authors:  Kei Yamamoto; Yusuke Asai; Issaku Nakatani; Kenichi Hayashi; Hidenori Nakagawa; Koh Shinohara; Shinichiro Kanai; Michitsugu Shimatani; Masaya Yamato; Nobuyuki Shimono; Tsuyoshi Kitaura; Nobuhiro Komiya; Atsushi Nagasaka; Takahiro Mikawa; Akihiro Manabe; Takashi Matono; Yoshihiro Yamamoto; Taku Ogawa; Satoshi Kutsuna; Norio Ohmagari
Journal:  Trop Dis Travel Med Vaccines       Date:  2022-02-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.